Rheumatic mitral valve surgery: about 1025 cases
DOI:
https://doi.org/10.18203/2349-2902.isj20171633Keywords:
Rheumatic valvulopathy, Mitral valve, Valvular surgeryAbstract
Background: Rheumatic mitral valvulopathy is often associated with other valvulopathies. It remains endemic in developing countries where it is the leading cause of heart failure and cardiovascular death.
Methods: This study provides a retrospective analysis of 1025 cases involving patients who underwent mitral valve surgery at Ibn Sina Hospital in Rabat, Morocco between the dates of January 2, 2001 and April 5, 2012. Preoperatively a clinical and paraclinical assessment has been established.
Results: The predominant valvular defects are mitral stenosis, functional tricuspid insufficiency. The gesture was a first intervention in 93% of the cases, with mitral valve replacement in 90% of cases and plasty in 10% of the cases.
Conclusions: These patients deserve more accurate evaluation in the choice of the surgical strategy which strongly impacts the post-operative outcomes. This report discusses the factors supporting mitral repair surgery in rheumatic disease, according to the patients' characteristics and the effectiveness of the current repair techniques compared to prosthetic valve replacement in developing countries.
References
Nkomo VT, Gardin JM, Skelton TN, Gohdiener JS, Scoh CG, Enriquez Sarano M. Burden of valvular heart diseases: a population-based study. The Lancet. 2006;368:1005-11.
Sekkali N, EL Ouali L, Akoudad H. Rhumatisme articulaire aigu. Morrocan J Cardiol. 2010(2):28-33.
Shinn HOS, Young NA. Short- and long-term results of triple valve surgery: a single center experience. J Korean Med Sci. 2009;24:818-23.
Panda BR, Shankar R, Kuruvilla KT, Philip MA, Thankachen R, Shukla V, et al. Combined mitral and aortic valve replacement for rheumatic heart disease: fifteen-year follow up and long-term results. J Heart Valve Dis. 2009;18:170-9.
Eukouhen D. Cardiopathies valvulaires évoluées: Prise en charge chirurgicale (à propos de 59 cas) service de chirurgie cardio-vasculaire du centre hospitalier universitaire IBN ROCHD; 2007:48.
Davoodi S, Karimi A, Ahmadi SH. Short- and mid-term results of triplevalve surgery with an evaluation of postoperative quality of life. Tex Heart Inst J. 2009;36(2):125-30.
Belfquih O. Prise en charge chirurgicale de l’atteinte mitrale au sein du service de chirurgie cardiaque de CHU HASSAN II de Fès (A propos de 100cas); 2013:17.
Luxereau P, Iung B. Rétrécissement mitral. Traité de cardiologie. 1998;11-010-A10.
Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E. Systemic embolism in mitral valve disease. Br Heart J. 1970;32:26-34.
Daley R, Mattingly TW, Holt CL, Bloud EF, White PD. Systematic arterial embolism in rheumatic Heart disease. Am Heart J. 1951;42:566-81.
Zouaoui W. Short-and long-term results of mitral replacement by cagedball and bileaflet mechanical prosthesis. Ann Cardiol Angiol. 2009;58:86-93.
Hann QQ, Xu ZY, Zou LJ. Primary triple valve surgery for advanced rheumatic heart disease in Mainland China: a single-center experience with 871 clinical cases. Eur J Cardiovasc Surg. 2007;31:845-50.
Alsoufi B, Rao V, Borger MA, Maganti M, Armstrong S, Feindel CM, et al. Short and long-term results of triple valve surgery in the modern era. Ann Thorac Surg. 2006;81:2172-8.
Izumi C, Iga K, Konishi T. Progression of isolated tricuspid regurgitation late after mitral valve surgery for rheumatic mitral valve disease. J Heart Valve Dis. 2002;11:353-6.
Pathan AZ, Mahdi NA, Leon MN. Is redo percutaneous mitral balloon valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis? J Am Coll Cardiol. 1999;34:49-54.
Rifaie O, Ismail M, Nammas W. Immediate and long-term outcome of redopercutaneous mitral valvuloplasty: comparison with initial procedure in patients with rheumatic mitral restenosis. J Interv Cardiol. 2010;23:1-6.
Aslanabadi N, Golmohammadi A, Sohrabi B, Kazemi B. Repeat percutaneous balloon mitral valvotomy vs mitral valve replacement in patients with restenosis after previous balloon mitral valvotomy and unfavorable valve characteristics. Clin Cardiol. 2011;34:401-6.
Fawzy ME, Hassan W, Shoukri M. Immediate and long-term results of mitral balloon valvotomy for restenosis following previous surgical or balloon mitral commissurotomy. Am J Cardiol. 2005;96:971-5.
Bruce CJ, Connolly HM. Right-sided valve disease deserves a little more respect. Circulation. 2009;119:2726-34.
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405-9.
Dreyfus GD, Corbi PJ, Chan KM. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005;79:127-32.
Aouifi A. Sortie de CEC difficile. Tableaux cliniques et modalités thérapeutiques. ITBM-RBM. 2006;27:S68-S73.
Muller M, Junger A, Brau M, Kwapisz ram, Schindler E, Akinturk H. Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system. Br J Anaesth. 2002;89(3):398-404.
Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery - a systematic literature review. Crit Care. 2005;9(3):266-79.
Light RW, Rogers JT, Moyers RJ. Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Am J Respir Crit Care Med. 2002;166:1567-71.
Cove ME, Spelman DW, Maclaren. Infectious complications of cardiac surgery: a clinical review. J Cardiothorac Vasc Anesth. 2012;26:1094-100.
Royster R. Myocardial dysfunction following cardiopulmonary bypass: recovery patterns, predictors of inotropic needs, theoretical concepts of inotropic administration. J Cardiothor Vasc Anesth. 1993;7(suppl 2):19-25.
Mubeen M. Mitral valve replacement in severe pulmonary arterial hypertension. Asian Cardiovasc Thorac Ann. 2008;16:37-42.
Tempe DK. Evaluation and comparison of early hemodynamic changes after elective mitral valve replacement in patients with severe and mild pulmonary arterial hypertension. J Cardiothor Vascul Anesth. 2009;23(3):298-305.
Zielinski T, Pogorzelska H, Rajecka A, Biedermavn A. Pulmonary hemodynamics at rest and effort, 6 and 12 months after mitral valve replacement: a slow regression of effort pulmonary hypertension. Int J Cardiol. 1993;42:57-62.
Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol. 1991;17:1520-6.
